Not to mention........ countless partnerships........... and insiders
plus BP cos like Roche and Medimune. .
Over at stock charts it looks like the PnF charts show .................
A Double top breakout on April 9, 2015
with Traditional scaling and 3 box reversal
and a Bullish price objective of $15. a share.
Sounds good to me. Check it out.
from wikipedia on hepatitis B ..............
About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%............ ...........snippet
Tons of relatively unknown biotechs with market caps of one to six billion or so.
See no reason why INO should not be one ot those w the market cap in the billions.
Another best in class award.
Some short covering
Another new phase test
Another partnership deal
Another major investor
Insiders continue to buy
Could it be ???????????
Amazing number of BP cos that could be very interested in INO,
not to mention the billion dollar biotechs that are relatively unknown vs BP
Gotta wonder what price would do the deed for a buyout of INO by Merck..............50 + ? .
BP clearly has not gone without noticing the validation and achievements of INO .
JNJ is the recent proof for that. .
Its all about market cap IMHO.
Too many biotechs with over one billion in market cap have nothing on little INO
Just hope any buyout offers are at a price of 50+ And thats Still not much in mkt caps.
Looks like its time for lunatic shorts to Go Figure
4/13/2015 Angel Cabrera Director Buy 8,000 $9.53 $76,240.00
10/9/2014 Peter Kies CFO Buy 3,960 $10.10 $39,996.00
8/21/2014 Morton Collins Director Buy 8,000 $10.01 $80,080.00
8/20/2014 Morton Collins Director Buy 40,600 $9.74 $395,444.00
8/12/2014 Joseph Kim CEO Buy 250,000 $9.06 $2,265,000.00
8/12/2014 Niranjan Sardesai COO Buy 2,550 $8.70 $22,185.00
4/15/2014 Jong Joseph Kim CEO Buy 25,000 $2.25 $56,250.00
11/13/2013 Mort Collins Dir. Buy 254,500 $1.82 $463,190.00
4/16/2013 Mark Bagarazzi Insider Buy 60,000 $0.56 $33,600.00
4/2/2013 Jong Joseph Kim CEO Buy 90,000 $0.50 $45,000.00
3/22/2013 Angel Cabrera Director Buy 40,000 $0.54 $21,600.00
3/20/2013 Jong Joseph Kim CEO Buy 60,000 $0.53 $31,800.00
3/20/2013 Niranjan Sardesai COO Buy 25,000 $0.53 $13,250.00 1/15/2013 Morton Collins Director Buy 100,000 $0.67 $67,000.00
Would this be some of your Evidence ?????????? ....
Inovio Pharmaceuticals' HPV Immunotherapy Recognized as "Best Therapeutic Vaccine" by World Vaccine Congress ......GlobeNewswire
from market pulse / stock twits re LOONS.
.........short position up 1.5 million to 12.96 million shares short on 3/31.
Imagine the volume if all these loons want out at $14-$16/share
.... it looks like .JNJ has just belatedly, in effect, admitted that electroportation is 1000 times more effective than conventional injection of DNA drugs.
Seems to certainly validate ALL the INOVIO technologies.
So where does that leave the other BP companies ?????????
Looks like we are going vertical today.
Excellent ideas. Great post.
...and lets hope the ignorant one line bashers attempts to spread FUD may soon be ending.
Look like something is up..